A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/553 (2006.01) A61P 1/04 (2006.01) A61P 3/04 (2006.01) A61P 9/00 (2006.01) A61P 13/00 (2006.01) A61P 17/00 (2006.01) A61P 19/00 (2006.01) A61P 25/00 (2006.01) A61P 31/00 (2006.01) A61P 33/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2575272
The present invention relates to the use of K-252a, a physiologically active substance produced by microorganisms, and of its salts or synthetic and/or chemically modified derivatives for the prevention or treatment of HMGB1~associated pathologies. More particularly, the present invention relates to the use of K-252a for the prevention or treatment of restenosis.
La présente invention concerne l'utilisation de K-252a, substance physiologiquement active produite par des micro-organismes ainsi que de ses sels ou de dérivés synthétiques ou chimiquement modifiés de cette substance pour la prévention ou le traitement de pathologies associées à HMGB1. La présente invention concerne concerne plus particulièrement l'utilisation de K-252a pour la prévention ou le traitement de la resténose.
Barone Domenico
Bertarione Rava Rossa Luisa
Fumero Silvano
Mainero Valentina
Pilato Francesco P.
Bio3research Srl
Creabilis Therapeutics S.p.a.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Use of k-252a and kinase inhibitors for the prevention or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of k-252a and kinase inhibitors for the prevention or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of k-252a and kinase inhibitors for the prevention or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2003880